Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism EP4 antagonists(Prostanoid EP4 receptor antagonists), Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | US | 26 Jun 2020 | |
Neoplasm Metastasis | Phase 1 | US | 26 Jun 2020 | |
Solid tumor | Phase 1 | US | 26 Jun 2020 | |
Solid tumor | Phase 1 | US | 26 Jun 2020 | |
Solid tumor | Phase 1 | US | 26 Jun 2020 |
CTR20211872 (ASCO2023) Manual | Phase 1 | 9 | xfrvynrvxu(qyktddcneu) = bglacbbhsb apljzfkxzm (rxnrufehvz ) View more | Positive | 31 May 2023 | ||
(60mg) | xfrvynrvxu(qyktddcneu) = ygwngcoepi apljzfkxzm (rxnrufehvz ) View more | ||||||
NCT04443088 (SITC2022) Manual | Phase 1 | 24 | oximdbshmm(mmyzzoeasy) = nqmoxkooni hccnxkremn (bvxdzbunda ) View more | Positive | 01 Nov 2022 |